Public Meeting: Patient-Focused Drug Development for Chagas Disease (Part 1 of 4)

preview_player
Показать описание
  1. U.S. Food and Drug Administration
  2. “patient-focused drug development”
  3. PFDD
  4. drugs
  5. “drug development”
  6. Chagas
Рекомендации по теме
Public Meeting: Patient-Focused 1:58:49

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 1)

Public Meeting: Patient-Focused 3:58:26

Public Meeting: Patient-Focused Drug Development for Systemic Sclerosis

Public Meeting: Patient-Focused 1:58:05

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

Public Meeting: Patient-Focused 1:32:12

Public Meeting: Patient-Focused Drug Development for Chagas Disease (Part 1 of 4)

Public Meeting: Patient-Focused 1:48:22

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 1)...

Public Webinar: Patient-Focused 1:59:38

Public Webinar: Patient-Focused Drug Development Draft Guidance 4

Virtual Public Meeting 5:18:41

Virtual Public Meeting on Patient-Focused Drug Development for Long COVID

Public Meeting on 1:48:42

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 2

PD 10 – 1:33:15

PD 10 – Driving Action: Innovation & Access for Resilient Responses Against AMR

Public Meeting: Patient-Focused 3:57:57

Public Meeting: Patient-Focused Drug Development for Vitiligo

Public Meeting on 2:07:05

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 1

Public Meeting: Patient-Focused 1:54:32

Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2)

Public Meeting: Patient-Focused 4:16:21

Public Meeting: Patient-Focused Drug Development for Stimulant Use Disorder

Public Meeting on 1:48:56

Public Meeting on Patient Focused Drug Development for Non Tuberculous Mycobacterial Infections Pt 1

Public Meeting on 1:47:12

Public Meeting on Patient Focused Drug Development for Functional GI Disorders Part 2

Public Meeting on 1:14:05

Public Meeting on Patient Focused Drug Development for Non Tuberculous Mycobacterial Infections Pt 2

Public Meeting: Patient-Focused 2:30:29

Public Meeting: Patient-Focused Drug Development for Hereditary Angioedema (Part 1 of 2)

Public Webinar: Patient-Focused 2:34:13

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

Public Meeting on 1:59:53

Public Meeting on Patient Focused Drug Development for Functional GI Disorders Part 1

Public Meeting: Patient-Focused 2:18:58

Public Meeting: Patient-Focused Drug Development for Female Sexual Dysfunction (Part 1 of 2)

Public Meeting: Patient-Focused 1:49:05

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 2 of 2)

Public Meeting: Patient-Focused 2:36:58

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 2)

Public Meeting: Patient-Focused 0:51:39

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)

Public Meeting: Patient-Focused 2:44:46

Public Meeting: Patient-Focused Drug Development for Hemophilia A, B, & Other Bleeding Disorders...